C9 and myeloid sarcoma: In this work we have highlighted two proteins in plasma, i.e., C9 and CYP24A1, that could be regarded as putative diagnostic biomarkers for MS as their level in plasma was increased in affected subjects as compared to controls, which may serve as a good basis to extend the current understanding of the disease and the literature regarding biomarkers for MS in plasma.